ATB-1011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATB-1011, covering 2023-02-01 to 2023-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes [Phase 3]